One Exchange Square
8 Connaught Place
Central, Hong Kong
Our lawyers in Asia are qualified to practice law in a wide-range of locations including Hong Kong, the People’s Republic of China and Taiwan, India, England, Wales, the U.S. and Canada. Our attorneys based in Hong Kong are also multilingual and speak English, Mandarin, Cantonese, Taiwanese and Hindi.
Our comprehensive Asia practice is focused on Capital Markets, Corporate, Mergers + Acquisitions, Debt Finance, Private Equity, Private Investment Funds, Venture Capital, Life Sciences, Real Estate and TMT (Technology, Media & Telecom) sectors. With the breakneck pace of technology disrupting industries around the world, we partner with our clients and embrace the promise and potential of innovation to make a lasting impact. More broadly, Goodwin has assembled a global team that we believe is unique in BigLaw – a team that is equally proficient in advising the innovators and the investors across the private equity, technology, healthcare and life sciences sectors.
We have been named Top Law Firm in Private Equity & Venture Capital by China Business Law Journal in 2017-2018, a Leading International Firm for India-related work by India Business Law Journal since 2008, and a Leading Law Firm for Corporate/M&A (International Firms) in India by Chambers Asia Pacific for many years including recently in 2018.
Hong Kong Celebrates 10 Years
Market-Leading TMT Practice
Our technology, media and telecom (TMT) practice covers a broad range of corporate transactions. Our expertise in private equity and growth equity, pooled investments and funds, international capital-raising and exchange listing activities, cross-border M&A, as well as joint ventures and restructurings have led to working with well-known technology investors and companies. These include transactions involving AbsolutData, Alibaba Group, BillDesk, Canyon Bridge, Crystal Stream, Didi Chuxing, DST Global, Falcon Edge Capital, Flipkart, FountainVest Partners, Fractal Analytics, Go Jek, Hillhouse Capital, Horizons Ventures, IMAX, JD.com, Koudai, Meituan, Micromax, Olacabs, Quilvest, RRE Ventures, Snapdeal, Tencent, Vy Capital, Xiaomi, Zodius/Advendus Capital, and Zomato.
Life Sciences Expertise
Our highly-experienced life sciences lawyers help clients find strategic paths that foster growth and minimize risk across all phases of the corporate life cycle. We’ve helped serve all legal needs for global life sciences companies with IPOs, mergers and acquisitions, licensing, royalty monetization, strategic guidance and regulatory framework.. Our recent Asia experience includes advising on the Hong Kong IPOs of AOBiome and Ascentage, and BeiGene’s US IPO, as well as leading Asia-based private equity funds on their investments in the life sciences sector.